Korro Bio scores $116m Series B
Korro Bio, Inc., a RNA editing company, has closed $116 million in Series B financing.
Korro Bio, Inc., a RNA editing company, has closed $116 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination